Share Price and Basic Stock Data
Last Updated: January 14, 2026, 1:43 pm
| PEG Ratio | -1.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Prolife Industries Ltd operates within the Dyes & Pigments sector and reported a market capitalization of ₹26.2 Cr. The company’s revenue from operations for the fiscal year ending March 2023 stood at ₹78.15 Cr, reflecting a slight decrease from ₹73.08 Cr in the previous fiscal year. The sales trajectory shows variability, with quarterly sales peaking at ₹42.96 Cr in September 2022 but declining to ₹29.86 Cr by September 2023. The total sales for TTM reported at ₹57.54 Cr indicate a contraction compared to the previous year’s ₹73.08 Cr. This fluctuation can be attributed to changing market dynamics and demand for dye products. Despite this, the company has maintained a consistent operational presence, which is crucial for long-term sustainability. The reported operating profit margin (OPM) of 7.44% for the latest period demonstrates some resilience, although it is lower than the prior quarter’s high of 23.21%. Overall, the revenue trends depict a cautious outlook, necessitating strategic measures to stabilize and enhance sales performance.
Profitability and Efficiency Metrics
Prolife Industries Ltd has demonstrated varied profitability metrics over recent reporting periods. The net profit for the fiscal year ending March 2023 was recorded at ₹6.91 Cr, a decline from ₹8.76 Cr in March 2024. The company’s earnings per share (EPS) stood at ₹16.88, which reflects strong profitability, although it is lower than the previous year’s ₹21.40. The return on equity (ROE) was reported at 10.8%, indicating effective utilization of shareholders’ funds despite the challenges. Meanwhile, the interest coverage ratio (ICR) of 23.12x signifies robust ability to cover interest expenses, enhancing financial stability. However, the cash conversion cycle (CCC) of 94 days suggests inefficiencies in working capital management, which could affect liquidity. The operating profit margin (OPM) of 7.44% points to a need for improved cost management strategies to enhance profitability. Overall, while the company has maintained a reasonable level of profitability, addressing operational inefficiencies is essential for future growth.
Balance Sheet Strength and Financial Ratios
The balance sheet of Prolife Industries Ltd reflects a stable financial position, with total assets amounting to ₹53.32 Cr as of March 2025. The company reported reserves of ₹42.87 Cr, indicating strong retained earnings and financial resilience. Borrowings are notably low at ₹0.27 Cr, resulting in a total debt-to-equity ratio of 0.05, which is substantially lower than industry averages, suggesting prudent financial management and minimal leverage. The current ratio of 6.99x is significantly above the typical threshold of 1.5, indicating strong liquidity and the ability to meet short-term obligations comfortably. Furthermore, the price-to-book value (P/BV) ratio of 1.98x suggests that the stock may be fairly valued compared to its book value. However, the return on capital employed (ROCE) ratio of 14.4% indicates room for improvement in generating returns from capital investments. Overall, the balance sheet is robust, but enhancing capital efficiency remains a priority.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Prolife Industries Ltd indicates a strong promoter presence, with promoters holding 73.74% of the equity as of September 2025. This substantial stake reflects confidence in the company’s long-term strategy and operational performance. The public holding stands at 26.26%, with the total number of shareholders increasing from 133 in September 2021 to 487 by September 2025, highlighting growing investor interest. However, the absence of foreign institutional investors (FIIs) and domestic institutional investors (DIIs) may suggest limited institutional backing, which could affect market perception and stock liquidity. The dividend payout ratio of 4.37% reflects a conservative approach to distributing profits, allowing for reinvestment into the business. While the promoter’s significant stake can be seen as a strength, the lack of broader institutional participation may pose a risk to overall market confidence. Thus, fostering institutional interest could enhance the stock’s attractiveness.
Outlook, Risks, and Final Insight
The outlook for Prolife Industries Ltd hinges on its ability to navigate the challenges presented by recent revenue declines and operational inefficiencies. Strengths include a solid balance sheet with minimal debt and a strong promoter backing, which could provide stability during turbulent market conditions. However, risks remain, including the need for improved working capital management, as indicated by the high cash conversion cycle, and potential market volatility affecting demand for dyes and pigments. The company’s profitability metrics, while stable, indicate a need for strategic adjustments to enhance operational efficiency and profitability. As the company seeks to expand its market presence, it must also focus on enhancing investor confidence to attract institutional investors. Overall, a proactive approach to addressing these challenges while leveraging its strengths could position Prolife Industries for improved performance in the future.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Deepak Chemtex Ltd | 109 Cr. | 100 | 170/93.5 | 13.2 | 52.4 | 0.00 % | 28.1 % | 20.9 % | 10.0 |
| Prolife Industries Ltd | 26.2 Cr. | 64.0 | 286/64.0 | 10.9 | 115 | 0.47 % | 14.4 % | 10.8 % | 10.0 |
| Industry Average | 109.00 Cr | 82.00 | 12.05 | 83.70 | 0.24% | 21.25% | 15.85% | 10.00 |
Quarterly Result
| Metric | Sep 2019 | Mar 2020 | Sep 2020 | Mar 2021 | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 23.27 | 27.18 | 33.33 | 40.26 | 34.89 | 38.31 | 42.96 | 35.36 | 29.86 | 26.96 | 26.68 | 28.79 | 28.75 |
| Expenses | 21.07 | 23.86 | 29.09 | 36.31 | 31.05 | 36.18 | 38.44 | 31.15 | 22.93 | 22.08 | 21.58 | 28.22 | 26.61 |
| Operating Profit | 2.20 | 3.32 | 4.24 | 3.95 | 3.84 | 2.13 | 4.52 | 4.21 | 6.93 | 4.88 | 5.10 | 0.57 | 2.14 |
| OPM % | 9.45% | 12.21% | 12.72% | 9.81% | 11.01% | 5.56% | 10.52% | 11.91% | 23.21% | 18.10% | 19.12% | 1.98% | 7.44% |
| Other Income | 0.68 | 1.10 | 0.23 | 0.39 | 0.51 | 1.11 | 0.85 | 1.33 | 0.51 | 1.08 | 0.45 | 1.63 | 0.55 |
| Interest | 0.49 | 0.10 | 0.29 | 0.20 | 0.25 | 0.21 | 0.39 | 0.03 | 0.20 | 0.13 | 0.18 | 0.15 | 0.09 |
| Depreciation | 0.51 | 0.52 | 0.50 | 0.43 | 0.48 | 0.68 | 0.62 | 0.63 | 0.62 | 0.59 | 0.56 | 0.54 | 0.59 |
| Profit before tax | 1.88 | 3.80 | 3.68 | 3.71 | 3.62 | 2.35 | 4.36 | 4.88 | 6.62 | 5.24 | 4.81 | 1.51 | 2.01 |
| Tax % | 29.79% | 28.42% | 26.09% | 25.34% | 20.72% | 39.15% | 20.87% | 28.89% | 25.08% | 27.48% | 21.83% | 38.41% | 25.87% |
| Net Profit | 1.32 | 2.72 | 2.73 | 2.77 | 2.87 | 1.43 | 3.45 | 3.46 | 4.96 | 3.80 | 3.75 | 0.92 | 1.49 |
| EPS in Rs | 3.22 | 6.64 | 6.67 | 6.77 | 7.01 | 3.49 | 8.43 | 8.45 | 12.11 | 9.28 | 9.16 | 2.25 | 3.64 |
Last Updated: December 29, 2025, 12:04 pm
Below is a detailed analysis of the quarterly data for Prolife Industries Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 28.75 Cr.. The value appears to be declining and may need further review. It has decreased from 28.79 Cr. (Mar 2025) to 28.75 Cr., marking a decrease of 0.04 Cr..
- For Expenses, as of Sep 2025, the value is 26.61 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 28.22 Cr. (Mar 2025) to 26.61 Cr., marking a decrease of 1.61 Cr..
- For Operating Profit, as of Sep 2025, the value is 2.14 Cr.. The value appears strong and on an upward trend. It has increased from 0.57 Cr. (Mar 2025) to 2.14 Cr., marking an increase of 1.57 Cr..
- For OPM %, as of Sep 2025, the value is 7.44%. The value appears strong and on an upward trend. It has increased from 1.98% (Mar 2025) to 7.44%, marking an increase of 5.46%.
- For Other Income, as of Sep 2025, the value is 0.55 Cr.. The value appears to be declining and may need further review. It has decreased from 1.63 Cr. (Mar 2025) to 0.55 Cr., marking a decrease of 1.08 Cr..
- For Interest, as of Sep 2025, the value is 0.09 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.15 Cr. (Mar 2025) to 0.09 Cr., marking a decrease of 0.06 Cr..
- For Depreciation, as of Sep 2025, the value is 0.59 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.54 Cr. (Mar 2025) to 0.59 Cr., marking an increase of 0.05 Cr..
- For Profit before tax, as of Sep 2025, the value is 2.01 Cr.. The value appears strong and on an upward trend. It has increased from 1.51 Cr. (Mar 2025) to 2.01 Cr., marking an increase of 0.50 Cr..
- For Tax %, as of Sep 2025, the value is 25.87%. The value appears to be improving (decreasing) as expected. It has decreased from 38.41% (Mar 2025) to 25.87%, marking a decrease of 12.54%.
- For Net Profit, as of Sep 2025, the value is 1.49 Cr.. The value appears strong and on an upward trend. It has increased from 0.92 Cr. (Mar 2025) to 1.49 Cr., marking an increase of 0.57 Cr..
- For EPS in Rs, as of Sep 2025, the value is 3.64. The value appears strong and on an upward trend. It has increased from 2.25 (Mar 2025) to 3.64, marking an increase of 1.39.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:47 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 18.95 | 19.58 | 22.19 | 27.14 | 27.20 | 29.58 | 50.38 | 73.50 | 73.08 | 78.15 | 56.81 | 55.35 | 57.54 |
| Expenses | 17.49 | 17.76 | 20.39 | 24.60 | 23.65 | 25.38 | 44.82 | 65.28 | 67.10 | 69.41 | 45.00 | 49.67 | 54.83 |
| Operating Profit | 1.46 | 1.82 | 1.80 | 2.54 | 3.55 | 4.20 | 5.56 | 8.22 | 5.98 | 8.74 | 11.81 | 5.68 | 2.71 |
| OPM % | 7.70% | 9.30% | 8.11% | 9.36% | 13.05% | 14.20% | 11.04% | 11.18% | 8.18% | 11.18% | 20.79% | 10.26% | 4.71% |
| Other Income | 0.10 | 0.31 | 0.45 | 0.10 | 0.27 | 0.46 | 1.78 | 0.62 | 1.63 | 2.18 | 1.59 | 2.08 | 2.18 |
| Interest | 0.87 | 1.11 | 1.01 | 0.84 | 0.84 | 0.91 | 0.63 | 0.52 | 0.48 | 0.43 | 0.33 | 0.34 | 0.24 |
| Depreciation | 0.29 | 0.40 | 0.42 | 0.47 | 0.89 | 0.93 | 1.03 | 0.93 | 1.16 | 1.25 | 1.21 | 1.10 | 1.13 |
| Profit before tax | 0.40 | 0.62 | 0.82 | 1.33 | 2.09 | 2.82 | 5.68 | 7.39 | 5.97 | 9.24 | 11.86 | 6.32 | 3.52 |
| Tax % | 45.00% | 37.10% | 35.37% | 33.83% | 28.23% | 28.01% | 28.87% | 25.58% | 27.97% | 25.11% | 26.14% | 25.79% | |
| Net Profit | 0.22 | 0.40 | 0.53 | 0.87 | 1.50 | 2.04 | 4.04 | 5.50 | 4.30 | 6.91 | 8.76 | 4.68 | 2.41 |
| EPS in Rs | 1.47 | 2.68 | 3.55 | 2.13 | 3.66 | 4.98 | 9.87 | 13.43 | 10.50 | 16.88 | 21.40 | 11.43 | 5.89 |
| Dividend Payout % | 20.32% | 8.94% | 7.03% | 9.40% | 6.82% | 6.01% | 3.04% | 2.23% | 2.85% | 1.78% | 2.33% | 2.62% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 81.82% | 32.50% | 64.15% | 72.41% | 36.00% | 98.04% | 36.14% | -21.82% | 60.70% | 26.77% | -46.58% |
| Change in YoY Net Profit Growth (%) | 0.00% | -49.32% | 31.65% | 8.26% | -36.41% | 62.04% | -61.90% | -57.96% | 82.52% | -33.92% | -73.35% |
Prolife Industries Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 2% |
| 3 Years: | -9% |
| TTM: | -2% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 28% |
| 5 Years: | 3% |
| 3 Years: | 3% |
| TTM: | -47% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 29% |
| 3 Years: | -6% |
| 1 Year: | -50% |
| Return on Equity | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 20% |
| 3 Years: | 19% |
| Last Year: | 11% |
Last Updated: September 5, 2025, 12:45 pm
Balance Sheet
Last Updated: December 4, 2025, 1:50 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 1.49 | 1.49 | 1.49 | 4.09 | 4.09 | 4.09 | 4.09 | 4.09 | 4.09 | 4.09 | 4.09 | 4.09 | 4.09 |
| Reserves | 1.04 | 1.53 | 2.10 | 4.59 | 6.00 | 8.03 | 11.92 | 17.30 | 21.48 | 28.27 | 36.90 | 41.38 | 42.87 |
| Borrowings | 9.60 | 10.10 | 8.61 | 5.07 | 4.82 | 7.15 | 7.71 | 5.49 | 4.71 | 1.92 | 3.81 | 2.58 | 0.27 |
| Other Liabilities | 4.07 | 4.57 | 3.84 | 4.77 | 6.22 | 7.42 | 11.94 | 21.75 | 25.15 | 6.88 | 7.12 | 5.27 | 13.74 |
| Total Liabilities | 16.20 | 17.69 | 16.04 | 18.52 | 21.13 | 26.69 | 35.66 | 48.63 | 55.43 | 41.16 | 51.92 | 53.32 | 60.97 |
| Fixed Assets | 2.29 | 2.73 | 3.21 | 8.11 | 9.56 | 10.04 | 9.60 | 9.34 | 11.43 | 11.36 | 11.29 | 10.51 | 7.55 |
| CWIP | 0.13 | 0.13 | 0.57 | 0.53 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 2.86 | 2.87 | 2.81 | 1.52 | 1.77 | 1.76 | 1.22 | 1.22 | 1.22 | 1.21 | 1.21 | 1.21 | 3.58 |
| Other Assets | 10.92 | 11.96 | 9.45 | 8.36 | 9.80 | 14.89 | 24.84 | 38.07 | 42.78 | 28.59 | 39.42 | 41.60 | 49.84 |
| Total Assets | 16.20 | 17.69 | 16.04 | 18.52 | 21.13 | 26.69 | 35.66 | 48.63 | 55.43 | 41.16 | 51.92 | 53.32 | 60.97 |
Below is a detailed analysis of the balance sheet data for Prolife Industries Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 4.09 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 4.09 Cr..
- For Reserves, as of Sep 2025, the value is 42.87 Cr.. The value appears strong and on an upward trend. It has increased from 41.38 Cr. (Mar 2025) to 42.87 Cr., marking an increase of 1.49 Cr..
- For Borrowings, as of Sep 2025, the value is 0.27 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 2.58 Cr. (Mar 2025) to 0.27 Cr., marking a decrease of 2.31 Cr..
- For Other Liabilities, as of Sep 2025, the value is 13.74 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 5.27 Cr. (Mar 2025) to 13.74 Cr., marking an increase of 8.47 Cr..
- For Total Liabilities, as of Sep 2025, the value is 60.97 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 53.32 Cr. (Mar 2025) to 60.97 Cr., marking an increase of 7.65 Cr..
- For Fixed Assets, as of Sep 2025, the value is 7.55 Cr.. The value appears to be declining and may need further review. It has decreased from 10.51 Cr. (Mar 2025) to 7.55 Cr., marking a decrease of 2.96 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 3.58 Cr.. The value appears strong and on an upward trend. It has increased from 1.21 Cr. (Mar 2025) to 3.58 Cr., marking an increase of 2.37 Cr..
- For Other Assets, as of Sep 2025, the value is 49.84 Cr.. The value appears strong and on an upward trend. It has increased from 41.60 Cr. (Mar 2025) to 49.84 Cr., marking an increase of 8.24 Cr..
- For Total Assets, as of Sep 2025, the value is 60.97 Cr.. The value appears strong and on an upward trend. It has increased from 53.32 Cr. (Mar 2025) to 60.97 Cr., marking an increase of 7.65 Cr..
Notably, the Reserves (42.87 Cr.) exceed the Borrowings (0.27 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -8.14 | -8.28 | -6.81 | -2.53 | -1.27 | -2.95 | -2.15 | 2.73 | 1.27 | 6.82 | 8.00 | 3.10 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 53.16 | 62.64 | 63.66 | 57.56 | 38.11 | 100.44 | 52.16 | 78.46 | 83.76 | 49.55 | 34.44 | 55.79 |
| Inventory Days | 162.19 | 170.77 | 69.16 | 43.03 | 65.17 | 37.05 | 62.59 | 52.32 | 76.79 | 39.40 | 63.68 | 68.39 |
| Days Payable | 77.54 | 91.39 | 68.73 | 71.78 | 104.12 | 104.55 | 89.97 | 124.33 | 149.89 | 25.99 | 37.71 | 30.18 |
| Cash Conversion Cycle | 137.82 | 142.02 | 64.08 | 28.81 | -0.84 | 32.93 | 24.78 | 6.45 | 10.66 | 62.96 | 60.41 | 94.00 |
| Working Capital Days | 98.62 | 87.61 | 40.46 | 54.06 | 18.12 | 54.91 | 0.07 | 8.94 | 19.58 | 57.54 | 28.98 | 70.10 |
| ROCE % | 10.63% | 13.70% | 14.93% | 16.57% | 20.31% | 21.83% | 29.03% | 30.83% | 22.57% | 29.96% | 30.83% | 14.35% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 11.43 | 21.40 | 16.89 | 10.51 | 13.43 |
| Diluted EPS (Rs.) | 11.43 | 21.40 | 16.89 | 10.51 | 13.43 |
| Cash EPS (Rs.) | 14.11 | 24.36 | 19.94 | 13.33 | 15.71 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 111.07 | 100.14 | 79.04 | 62.46 | 52.25 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 111.07 | 100.14 | 79.04 | 62.46 | 52.25 |
| Dividend / Share (Rs.) | 0.30 | 0.50 | 0.30 | 0.30 | 0.30 |
| Revenue From Operations / Share (Rs.) | 135.49 | 138.79 | 191.28 | 178.80 | 179.74 |
| PBDIT / Share (Rs.) | 18.93 | 32.74 | 26.65 | 18.53 | 21.53 |
| PBIT / Share (Rs.) | 16.25 | 29.77 | 23.59 | 15.71 | 19.25 |
| PBT / Share (Rs.) | 15.43 | 28.96 | 22.55 | 14.59 | 18.05 |
| Net Profit / Share (Rs.) | 11.43 | 21.40 | 16.89 | 10.51 | 13.43 |
| PBDIT Margin (%) | 13.97 | 23.58 | 13.93 | 10.36 | 11.98 |
| PBIT Margin (%) | 11.99 | 21.45 | 12.33 | 8.78 | 10.71 |
| PBT Margin (%) | 11.39 | 20.86 | 11.79 | 8.15 | 10.04 |
| Net Profit Margin (%) | 8.43 | 15.41 | 8.82 | 5.87 | 7.47 |
| Return on Networth / Equity (%) | 10.28 | 21.36 | 21.36 | 16.82 | 25.70 |
| Return on Capital Employeed (%) | 13.67 | 26.89 | 26.13 | 20.71 | 29.84 |
| Return On Assets (%) | 8.77 | 16.87 | 16.79 | 7.76 | 11.30 |
| Long Term Debt / Equity (X) | 0.05 | 0.09 | 0.12 | 0.19 | 0.21 |
| Total Debt / Equity (X) | 0.05 | 0.09 | 0.05 | 0.18 | 0.25 |
| Asset Turnover Ratio (%) | 1.05 | 1.22 | 1.62 | 1.41 | 1.75 |
| Current Ratio (X) | 6.99 | 4.95 | 4.28 | 1.22 | 1.12 |
| Quick Ratio (X) | 5.56 | 4.11 | 2.90 | 0.74 | 0.76 |
| Inventory Turnover Ratio (X) | 9.01 | 5.57 | 5.93 | 5.78 | 7.85 |
| Dividend Payout Ratio (NP) (%) | 4.37 | 1.40 | 1.77 | 2.85 | 2.23 |
| Dividend Payout Ratio (CP) (%) | 3.54 | 1.23 | 1.50 | 2.24 | 1.91 |
| Earning Retention Ratio (%) | 95.63 | 98.60 | 98.23 | 97.15 | 97.77 |
| Cash Earning Retention Ratio (%) | 96.46 | 98.77 | 98.50 | 97.76 | 98.09 |
| Interest Coverage Ratio (X) | 23.12 | 40.07 | 25.77 | 16.53 | 17.93 |
| Interest Coverage Ratio (Post Tax) (X) | 14.95 | 27.19 | 17.33 | 10.37 | 12.19 |
| Enterprise Value (Cr.) | 75.27 | 68.98 | 86.71 | 71.22 | 25.38 |
| EV / Net Operating Revenue (X) | 1.36 | 1.21 | 1.11 | 0.97 | 0.34 |
| EV / EBITDA (X) | 9.71 | 5.15 | 7.95 | 9.39 | 2.88 |
| MarketCap / Net Operating Revenue (X) | 1.62 | 1.53 | 1.10 | 0.92 | 0.28 |
| Retention Ratios (%) | 95.62 | 98.59 | 98.22 | 97.14 | 97.76 |
| Price / BV (X) | 1.98 | 2.12 | 2.67 | 2.65 | 0.96 |
| Price / Net Operating Revenue (X) | 1.62 | 1.53 | 1.10 | 0.92 | 0.28 |
| EarningsYield | 0.05 | 0.10 | 0.08 | 0.06 | 0.26 |
After reviewing the key financial ratios for Prolife Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 11.43. This value is within the healthy range. It has decreased from 21.40 (Mar 24) to 11.43, marking a decrease of 9.97.
- For Diluted EPS (Rs.), as of Mar 25, the value is 11.43. This value is within the healthy range. It has decreased from 21.40 (Mar 24) to 11.43, marking a decrease of 9.97.
- For Cash EPS (Rs.), as of Mar 25, the value is 14.11. This value is within the healthy range. It has decreased from 24.36 (Mar 24) to 14.11, marking a decrease of 10.25.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 111.07. It has increased from 100.14 (Mar 24) to 111.07, marking an increase of 10.93.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 111.07. It has increased from 100.14 (Mar 24) to 111.07, marking an increase of 10.93.
- For Dividend / Share (Rs.), as of Mar 25, the value is 0.30. This value is below the healthy minimum of 1. It has decreased from 0.50 (Mar 24) to 0.30, marking a decrease of 0.20.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 135.49. It has decreased from 138.79 (Mar 24) to 135.49, marking a decrease of 3.30.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 18.93. This value is within the healthy range. It has decreased from 32.74 (Mar 24) to 18.93, marking a decrease of 13.81.
- For PBIT / Share (Rs.), as of Mar 25, the value is 16.25. This value is within the healthy range. It has decreased from 29.77 (Mar 24) to 16.25, marking a decrease of 13.52.
- For PBT / Share (Rs.), as of Mar 25, the value is 15.43. This value is within the healthy range. It has decreased from 28.96 (Mar 24) to 15.43, marking a decrease of 13.53.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 11.43. This value is within the healthy range. It has decreased from 21.40 (Mar 24) to 11.43, marking a decrease of 9.97.
- For PBDIT Margin (%), as of Mar 25, the value is 13.97. This value is within the healthy range. It has decreased from 23.58 (Mar 24) to 13.97, marking a decrease of 9.61.
- For PBIT Margin (%), as of Mar 25, the value is 11.99. This value is within the healthy range. It has decreased from 21.45 (Mar 24) to 11.99, marking a decrease of 9.46.
- For PBT Margin (%), as of Mar 25, the value is 11.39. This value is within the healthy range. It has decreased from 20.86 (Mar 24) to 11.39, marking a decrease of 9.47.
- For Net Profit Margin (%), as of Mar 25, the value is 8.43. This value is within the healthy range. It has decreased from 15.41 (Mar 24) to 8.43, marking a decrease of 6.98.
- For Return on Networth / Equity (%), as of Mar 25, the value is 10.28. This value is below the healthy minimum of 15. It has decreased from 21.36 (Mar 24) to 10.28, marking a decrease of 11.08.
- For Return on Capital Employeed (%), as of Mar 25, the value is 13.67. This value is within the healthy range. It has decreased from 26.89 (Mar 24) to 13.67, marking a decrease of 13.22.
- For Return On Assets (%), as of Mar 25, the value is 8.77. This value is within the healthy range. It has decreased from 16.87 (Mar 24) to 8.77, marking a decrease of 8.10.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.05. This value is below the healthy minimum of 0.2. It has decreased from 0.09 (Mar 24) to 0.05, marking a decrease of 0.04.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.05. This value is within the healthy range. It has decreased from 0.09 (Mar 24) to 0.05, marking a decrease of 0.04.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.05. It has decreased from 1.22 (Mar 24) to 1.05, marking a decrease of 0.17.
- For Current Ratio (X), as of Mar 25, the value is 6.99. This value exceeds the healthy maximum of 3. It has increased from 4.95 (Mar 24) to 6.99, marking an increase of 2.04.
- For Quick Ratio (X), as of Mar 25, the value is 5.56. This value exceeds the healthy maximum of 2. It has increased from 4.11 (Mar 24) to 5.56, marking an increase of 1.45.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 9.01. This value exceeds the healthy maximum of 8. It has increased from 5.57 (Mar 24) to 9.01, marking an increase of 3.44.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 4.37. This value is below the healthy minimum of 20. It has increased from 1.40 (Mar 24) to 4.37, marking an increase of 2.97.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 3.54. This value is below the healthy minimum of 20. It has increased from 1.23 (Mar 24) to 3.54, marking an increase of 2.31.
- For Earning Retention Ratio (%), as of Mar 25, the value is 95.63. This value exceeds the healthy maximum of 70. It has decreased from 98.60 (Mar 24) to 95.63, marking a decrease of 2.97.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 96.46. This value exceeds the healthy maximum of 70. It has decreased from 98.77 (Mar 24) to 96.46, marking a decrease of 2.31.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 23.12. This value is within the healthy range. It has decreased from 40.07 (Mar 24) to 23.12, marking a decrease of 16.95.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 14.95. This value is within the healthy range. It has decreased from 27.19 (Mar 24) to 14.95, marking a decrease of 12.24.
- For Enterprise Value (Cr.), as of Mar 25, the value is 75.27. It has increased from 68.98 (Mar 24) to 75.27, marking an increase of 6.29.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.36. This value is within the healthy range. It has increased from 1.21 (Mar 24) to 1.36, marking an increase of 0.15.
- For EV / EBITDA (X), as of Mar 25, the value is 9.71. This value is within the healthy range. It has increased from 5.15 (Mar 24) to 9.71, marking an increase of 4.56.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.62. This value is within the healthy range. It has increased from 1.53 (Mar 24) to 1.62, marking an increase of 0.09.
- For Retention Ratios (%), as of Mar 25, the value is 95.62. This value exceeds the healthy maximum of 70. It has decreased from 98.59 (Mar 24) to 95.62, marking a decrease of 2.97.
- For Price / BV (X), as of Mar 25, the value is 1.98. This value is within the healthy range. It has decreased from 2.12 (Mar 24) to 1.98, marking a decrease of 0.14.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.62. This value is within the healthy range. It has increased from 1.53 (Mar 24) to 1.62, marking an increase of 0.09.
- For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has decreased from 0.10 (Mar 24) to 0.05, marking a decrease of 0.05.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Prolife Industries Ltd:
- Net Profit Margin: 8.43%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 13.67% (Industry Average ROCE: 21.25%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 10.28% (Industry Average ROE: 15.85%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 14.95
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 5.56
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 10.9 (Industry average Stock P/E: 12.05)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.05
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 8.43%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Dyes & Pigments | No. 213, G.I.D.C., Panoli, Ankleshwar Gujarat 394116 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Karan M Jolly | Managing Director |
| Mrs. Anureet Kaur Jolly | Director |
| Mr. Siddharth Raghuvanshi | Director |
| Mr. Veljibhai K Patel | Director |
| Mr. Dharmendra Pushkarna | Independent Director |
| Mr. Keshavkumar B Singh | Independent Director |
FAQ
What is the intrinsic value of Prolife Industries Ltd?
Prolife Industries Ltd's intrinsic value (as of 15 January 2026) is ₹108.81 which is 70.02% higher the current market price of ₹64.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹26.2 Cr. market cap, FY2025-2026 high/low of ₹286/64.0, reserves of ₹42.87 Cr, and liabilities of ₹60.97 Cr.
What is the Market Cap of Prolife Industries Ltd?
The Market Cap of Prolife Industries Ltd is 26.2 Cr..
What is the current Stock Price of Prolife Industries Ltd as on 15 January 2026?
The current stock price of Prolife Industries Ltd as on 15 January 2026 is ₹64.0.
What is the High / Low of Prolife Industries Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Prolife Industries Ltd stocks is ₹286/64.0.
What is the Stock P/E of Prolife Industries Ltd?
The Stock P/E of Prolife Industries Ltd is 10.9.
What is the Book Value of Prolife Industries Ltd?
The Book Value of Prolife Industries Ltd is 115.
What is the Dividend Yield of Prolife Industries Ltd?
The Dividend Yield of Prolife Industries Ltd is 0.47 %.
What is the ROCE of Prolife Industries Ltd?
The ROCE of Prolife Industries Ltd is 14.4 %.
What is the ROE of Prolife Industries Ltd?
The ROE of Prolife Industries Ltd is 10.8 %.
What is the Face Value of Prolife Industries Ltd?
The Face Value of Prolife Industries Ltd is 10.0.